- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Follow-on Biologics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Follow-on Biologics market. Detailed analysis of key players, along with key growth strategies adopted by Follow-on Biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celltrion
Biocon
Pfizer
Amgen
Stada Arzneimittel AG
Sandoz
Dr Reddy's Laboratories
Teva Pahrmaceutical
Mylan
Samsung Biologics
By Type:
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
By End-User:
Oncology
Blood Disorders
Chronic Diseases
Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Other Diseases
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Follow-on Biologics Market
-
1.3 Market Segment by Type
-
1.3.1 China Follow-on Biologics Market Size and Growth Rate of Recombinant Non-glycosylated Proteins from 2016 to 2027
-
1.3.2 China Follow-on Biologics Market Size and Growth Rate of Recombinant Glycosylated Proteins from 2016 to 2027
-
1.3.3 China Follow-on Biologics Market Size and Growth Rate of Recombinant Peptides from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Follow-on Biologics Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.2 China Follow-on Biologics Market Size and Growth Rate of Blood Disorders from 2016 to 2027
-
1.4.3 China Follow-on Biologics Market Size and Growth Rate of Chronic Diseases from 2016 to 2027
-
1.4.4 China Follow-on Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027
-
1.4.5 China Follow-on Biologics Market Size and Growth Rate of Growth Hormone Deficiency from 2016 to 2027
-
1.4.6 China Follow-on Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
1.4.7 China Follow-on Biologics Market Size and Growth Rate of Other Diseases from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Follow-on Biologics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Follow-on Biologics by Major Types
-
3.4.1 Market Size and Growth Rate of Recombinant Non-glycosylated Proteins
-
3.4.2 Market Size and Growth Rate of Recombinant Glycosylated Proteins
-
3.4.3 Market Size and Growth Rate of Recombinant Peptides
4 Segmentation of Follow-on Biologics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Follow-on Biologics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Follow-on Biologics in Oncology
-
4.4.2 Market Size and Growth Rate of Follow-on Biologics in Blood Disorders
-
4.4.3 Market Size and Growth Rate of Follow-on Biologics in Chronic Diseases
-
4.4.4 Market Size and Growth Rate of Follow-on Biologics in Autoimmune Diseases
-
4.4.5 Market Size and Growth Rate of Follow-on Biologics in Growth Hormone Deficiency
-
4.4.6 Market Size and Growth Rate of Follow-on Biologics in Infectious Diseases
-
4.4.7 Market Size and Growth Rate of Follow-on Biologics in Other Diseases
5 Market Analysis by Regions
-
5.1 China Follow-on Biologics Production Analysis by Regions
-
5.2 China Follow-on Biologics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Follow-on Biologics Landscape Analysis
-
6.1 North China Follow-on Biologics Landscape Analysis by Major Types
-
6.2 North China Follow-on Biologics Landscape Analysis by Major End-Users
7 Central China Follow-on Biologics Landscape Analysis
-
7.1 Central China Follow-on Biologics Landscape Analysis by Major Types
-
7.2 Central China Follow-on Biologics Landscape Analysis by Major End-Users
8 South China Follow-on Biologics Landscape Analysis
-
8.1 South China Follow-on Biologics Landscape Analysis by Major Types
-
8.2 South China Follow-on Biologics Landscape Analysis by Major End-Users
9 East China Follow-on Biologics Landscape Analysis
-
9.1 East China Follow-on Biologics Landscape Analysis by Major Types
-
9.2 East China Follow-on Biologics Landscape Analysis by Major End-Users
10 Northeast China Follow-on Biologics Landscape Analysis
-
10.1 Northeast China Follow-on Biologics Landscape Analysis by Major Types
-
10.2 Northeast China Follow-on Biologics Landscape Analysis by Major End-Users
11 Southwest China Follow-on Biologics Landscape Analysis
-
11.1 Southwest China Follow-on Biologics Landscape Analysis by Major Types
-
11.2 Southwest China Follow-on Biologics Landscape Analysis by Major End-Users
12 Northwest China Follow-on Biologics Landscape Analysis
-
12.1 Northwest China Follow-on Biologics Landscape Analysis by Major Types
-
12.2 Northwest China Follow-on Biologics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Celltrion
-
13.1.1 Celltrion Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Biocon
-
13.2.1 Biocon Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Pfizer
-
13.3.1 Pfizer Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Amgen
-
13.4.1 Amgen Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Stada Arzneimittel AG
-
13.5.1 Stada Arzneimittel AG Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Sandoz
-
13.6.1 Sandoz Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Dr Reddy's Laboratories
-
13.7.1 Dr Reddy's Laboratories Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Teva Pahrmaceutical
-
13.8.1 Teva Pahrmaceutical Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Mylan
-
13.9.1 Mylan Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Samsung Biologics
-
13.10.1 Samsung Biologics Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Follow-on Biologics Market Size and Growth Rate of Recombinant Non-glycosylated Proteins from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Recombinant Glycosylated Proteins from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Recombinant Peptides from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Blood Disorders from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Chronic Diseases from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Growth Hormone Deficiency from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
Figure China Follow-on Biologics Market Size and Growth Rate of Other Diseases from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Follow-on Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Follow-on Biologics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Follow-on Biologics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Follow-on Biologics by Different Types from 2016 to 2027
-
Table Consumption Share of Follow-on Biologics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Recombinant Non-glycosylated Proteins
-
Figure Market Size and Growth Rate of Recombinant Glycosylated Proteins
-
Figure Market Size and Growth Rate of Recombinant Peptides
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Follow-on Biologics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Follow-on Biologics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Blood Disorders
-
Figure Market Size and Growth Rate of Chronic Diseases
-
Figure Market Size and Growth Rate of Autoimmune Diseases
-
Figure Market Size and Growth Rate of Growth Hormone Deficiency
-
Figure Market Size and Growth Rate of Infectious Diseases
-
Figure Market Size and Growth Rate of Other Diseases
-
Table China Follow-on Biologics Production by Regions
-
Table China Follow-on Biologics Production Share by Regions
-
Figure China Follow-on Biologics Production Share by Regions in 2016
-
Figure China Follow-on Biologics Production Share by Regions in 2021
-
Figure China Follow-on Biologics Production Share by Regions in 2027
-
Table China Follow-on Biologics Consumption by Regions
-
Table China Follow-on Biologics Consumption Share by Regions
-
Figure China Follow-on Biologics Consumption Share by Regions in 2016
-
Figure China Follow-on Biologics Consumption Share by Regions in 2021
-
Figure China Follow-on Biologics Consumption Share by Regions in 2027
-
Table North China Follow-on Biologics Consumption by Types from 2016 to 2027
-
Table North China Follow-on Biologics Consumption Share by Types from 2016 to 2027
-
Figure North China Follow-on Biologics Consumption Share by Types in 2016
-
Figure North China Follow-on Biologics Consumption Share by Types in 2021
-
Figure North China Follow-on Biologics Consumption Share by Types in 2027
-
Table North China Follow-on Biologics Consumption by End-Users from 2016 to 2027
-
Table North China Follow-on Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Follow-on Biologics Consumption Share by End-Users in 2016
-
Figure North China Follow-on Biologics Consumption Share by End-Users in 2021
-
Figure North China Follow-on Biologics Consumption Share by End-Users in 2027
-
Table Central China Follow-on Biologics Consumption by Types from 2016 to 2027
-
Table Central China Follow-on Biologics Consumption Share by Types from 2016 to 2027
-
Figure Central China Follow-on Biologics Consumption Share by Types in 2016
-
Figure Central China Follow-on Biologics Consumption Share by Types in 2021
-
Figure Central China Follow-on Biologics Consumption Share by Types in 2027
-
Table Central China Follow-on Biologics Consumption by End-Users from 2016 to 2027
-
Table Central China Follow-on Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Follow-on Biologics Consumption Share by End-Users in 2016
-
Figure Central China Follow-on Biologics Consumption Share by End-Users in 2021
-
Figure Central China Follow-on Biologics Consumption Share by End-Users in 2027
-
Table South China Follow-on Biologics Consumption by Types from 2016 to 2027
-
Table South China Follow-on Biologics Consumption Share by Types from 2016 to 2027
-
Figure South China Follow-on Biologics Consumption Share by Types in 2016
-
Figure South China Follow-on Biologics Consumption Share by Types in 2021
-
Figure South China Follow-on Biologics Consumption Share by Types in 2027
-
Table South China Follow-on Biologics Consumption by End-Users from 2016 to 2027
-
Table South China Follow-on Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Follow-on Biologics Consumption Share by End-Users in 2016
-
Figure South China Follow-on Biologics Consumption Share by End-Users in 2021
-
Figure South China Follow-on Biologics Consumption Share by End-Users in 2027
-
Table East China Follow-on Biologics Consumption by Types from 2016 to 2027
-
Table East China Follow-on Biologics Consumption Share by Types from 2016 to 2027
-
Figure East China Follow-on Biologics Consumption Share by Types in 2016
-
Figure East China Follow-on Biologics Consumption Share by Types in 2021
-
Figure East China Follow-on Biologics Consumption Share by Types in 2027
-
Table East China Follow-on Biologics Consumption by End-Users from 2016 to 2027
-
Table East China Follow-on Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Follow-on Biologics Consumption Share by End-Users in 2016
-
Figure East China Follow-on Biologics Consumption Share by End-Users in 2021
-
Figure East China Follow-on Biologics Consumption Share by End-Users in 2027
-
Table Northeast China Follow-on Biologics Consumption by Types from 2016 to 2027
-
Table Northeast China Follow-on Biologics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Follow-on Biologics Consumption Share by Types in 2016
-
Figure Northeast China Follow-on Biologics Consumption Share by Types in 2021
-
Figure Northeast China Follow-on Biologics Consumption Share by Types in 2027
-
Table Northeast China Follow-on Biologics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Follow-on Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Follow-on Biologics Consumption Share by End-Users in 2016
-
Figure Northeast China Follow-on Biologics Consumption Share by End-Users in 2021
-
Figure Northeast China Follow-on Biologics Consumption Share by End-Users in 2027
-
Table Southwest China Follow-on Biologics Consumption by Types from 2016 to 2027
-
Table Southwest China Follow-on Biologics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Follow-on Biologics Consumption Share by Types in 2016
-
Figure Southwest China Follow-on Biologics Consumption Share by Types in 2021
-
Figure Southwest China Follow-on Biologics Consumption Share by Types in 2027
-
Table Southwest China Follow-on Biologics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Follow-on Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Follow-on Biologics Consumption Share by End-Users in 2016
-
Figure Southwest China Follow-on Biologics Consumption Share by End-Users in 2021
-
Figure Southwest China Follow-on Biologics Consumption Share by End-Users in 2027
-
Table Northwest China Follow-on Biologics Consumption by Types from 2016 to 2027
-
Table Northwest China Follow-on Biologics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Follow-on Biologics Consumption Share by Types in 2016
-
Figure Northwest China Follow-on Biologics Consumption Share by Types in 2021
-
Figure Northwest China Follow-on Biologics Consumption Share by Types in 2027
-
Table Northwest China Follow-on Biologics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Follow-on Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Follow-on Biologics Consumption Share by End-Users in 2016
-
Figure Northwest China Follow-on Biologics Consumption Share by End-Users in 2021
-
Figure Northwest China Follow-on Biologics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Stada Arzneimittel AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stada Arzneimittel AG
-
Figure Sales and Growth Rate Analysis of Stada Arzneimittel AG
-
Figure Revenue and Market Share Analysis of Stada Arzneimittel AG
-
Table Product and Service Introduction of Stada Arzneimittel AG
-
Table Company Profile and Development Status of Sandoz
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
-
Figure Sales and Growth Rate Analysis of Sandoz
-
Figure Revenue and Market Share Analysis of Sandoz
-
Table Product and Service Introduction of Sandoz
-
Table Company Profile and Development Status of Dr Reddy's Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories
-
Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories
-
Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories
-
Table Product and Service Introduction of Dr Reddy's Laboratories
-
Table Company Profile and Development Status of Teva Pahrmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pahrmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pahrmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pahrmaceutical
-
Table Product and Service Introduction of Teva Pahrmaceutical
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Samsung Biologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Biologics
-
Figure Sales and Growth Rate Analysis of Samsung Biologics
-
Figure Revenue and Market Share Analysis of Samsung Biologics
-
Table Product and Service Introduction of Samsung Biologics
-